Moffitt logo

Clinical Trials Search

Clinical Trial 22359

Cancer Type: Malignant Hematology
Study Type: Other

Phase: N/A
Principal Investigator: Oswald, Laura

Call 813-745-6100
or 1-800-679-0775 Learn More

Study Title

Sexual Health in Adolescent and Young Adult Patients after Chimeric Antigen Receptor T-Cell Therapy


The purpose of the study is to examine sexual health among young adult cancer survivors aged 18-39 years after chimeric antigen receptor T-cell (CAR-T) therapy. Investigators will also examine how health care providers communicate with patients about issues with their sexual health.


Our specific aims are to: Aim 1. Examine sexual health (i.e., sexual activity, dysfunction, and satisfaction) after CAR T-cell therapy among AYA cancer patients. Aim 2. Explore relationships between sexual health and other domains of HRQOL after CAR T-cell therapy among AYA cancer patients. Aim 3. Explore communication about sexual health between AYA recipients of CAR T-cell therapy and their healthcare providers.




Inclusion Criteria

  • 18-39 years old
  • Have undergone CAR T-cell therapy at Moffitt Cancer Center within the past 3 years
  • Have an expected survival of at least 3 months
  • Are able to speak and read English or Spanish
  • Have no documented or observational psychiatric or neurological disorders that could interfere with study participation (e.g., psychosis)
  • Are able to provide informed consent

  • Exclusion Criteria

  • Does not meet inclusion criteria

  • If you are interested in learning more about clinical trials, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.